Our CommitmentOur Commitment

Corbus is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways.

Learn More

Our ScienceOur Science

Corbus’ pipeline encompasses two different approaches to oncology with different risk profiles: a next-generation Nectin -4 Antibody Drug Conjugate (ADC) and monoclonal antibodies that target integrins to inhibit activation of TGFβ.

Learn More

Join Our Team

We are a unique team of individuals who are high-achieving, innovative, creative, and above all else, passionate about what we do.

A group photo of our team

Sign up for email alerts

Receive breaking news first.

Investor presentation

View our latest investor presentation.